RxDoctor Payments Data

Philip Ceraulo, DO

Physical Medicine & Rehabilitation · Union, NJNPI 1114180882

Payments from drug & device makers

$1,249in general payments, 2019–2025

Across 40 payments — averaging $31.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$239
  • Medtronic$211
  • SPR Therapeutics, Inc$161
  • Nalu Medical, Inc.$127
  • Nevro Corp.$101
  • Protega Pharmaceutials Inc$70
  • plus $341 from 13 others

What the payments were for

  • Food & beverage$1,21297%
  • Education$373%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,249 in reported general payments places this provider in the 80th percentile of 434 physical medicine & rehabilitation providers in New Jersey.

See all physical medicine & rehabilitation providers in New Jersey

Medicare billing

Part B allowed, 2024
$271,366
Medicare patients
335
Services billed
3,394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PercocetOxycodone Hcl/Acetaminophen52$132,353
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl108$19,003
OxycontinOxycodone Hcl24$11,203
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen416$9,585
Xtampza ErOxycodone Myristate20$6,561
Oxycodone Hcl280$5,809
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen208$4,293
Pregabalin338$4,086
Gabapentin468$3,387
Morphine Sulfate ErMorphine Sulfate83$2,517
Lidocaine23$1,668
Morphine Sulfate59$1,432
Lubiprostone11$1,297
Tizanidine Hcl175$1,279
Buprenorphine Hcl34$1,018

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$45$6,56120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 434 physical medicine & rehabilitation providers in New Jersey.

Other physical medicine & rehabilitation in Union

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →